Abstract:Background Individuals with Down syndrome (DS) have a heightened risk for various co‐occurring health conditions, including congenital heart disease (CHD). In this two‐part study, electronic medical records (EMRs) were leveraged to examine co‐occurring health conditions among individuals with DS (Study 1) and to investigate health conditions linked to surgical intervention among DS cases with CHD (Study 2). Methods De‐identified EMRs were acquired from Vanderbilt University Medical Center and facilitated creating a cohort of N = 2282 DS cases (55% females), along with comparison groups for each study. In Study 1, DS cases were one‐by‐two sex and age matched with samples of case–controls and of individuals with other intellectual and developmental difficulties (IDDs). The phenome‐disease association study (PheDAS) strategy was employed to reveal co‐occurring health conditions in DS versus comparison groups, which were then ranked for how often they are discussed in relation to DS using the PubMed database and Novelty Finding Index. In Study 2, a subset of DS individuals with CHD [N = 1098 (48%)] were identified to create longitudinal data for N = 204 cases with surgical intervention (19%) versus 204 case–controls. Data were included in predictive models and assessed which model‐based health conditions, when more prevalent, would increase the likelihood of surgical intervention. Results In Study 1, relative to case–controls and those with other IDDs, co‐occurring health conditions among individuals with DS were confirmed to include heart failure, pulmonary heart disease, atrioventricular block, heart transplant/surgery and primary pulmonary hypertension (circulatory); hypothyroidism (endocrine/metabolic); and speech and language disorder and Alzheimer's disease (neurological/mental). Findings also revealed more versus less prevalent co‐occurring health conditions in individuals with DS when comparing with those with other IDDs. Findings with high Novelty Finding Index were abnormal electrocardiogram, non‐rheumatic aortic valve disorders and heart failure (circulatory); acid–base balance disorder (endocrine/metabolism); and abnormal blood chemistry (symptoms). In Study 2, the predictive models revealed that among individuals with DS and CHD, presence of health conditions such as congestive heart failure (circulatory), valvular heart disease and cardiac shunt (congenital), and pleural effusion and pulmonary collapse (respiratory) were associated with increased likelihood of surgical intervention. Conclusions Research efforts using EMRs and rigorous statistical methods could shed light on the complexity in health profile among individuals with DS and other IDDs and motivate precision‐care development.

Pulmonary Hypertension in the Population with Down Syndrome

Clinical Characteristics and Risk Factors for Developing Pulmonary Hypertension in Children with Down Syndrome

Updated review on pulmonary arterial hypertension: Differences between down syndrome and non-down syndrome populations

Bosentan Treatment for Pulmonary Arterial Hypertension Due to Patent Ductus Arteriosus and Down's Syndrome in an Infant

Clinical Features and Prognosis of Bronchopulmonary Dysplasia Complicated by Pulmonary Hypertension in Preterm Infants

Prevalence of congenital heart defects and persistent pulmonary hypertension of the neonate with Down syndrome

What people with Down Syndrome can teach us about cardiopulmonary disease

Epigenetic Modulation in the Initiation and Progression of Pulmonary Hypertension.

Increased Lung Expression of Anti-Angiogenic Factors in Down Syndrome: Potential Role in Abnormal Lung Vascular Growth and the Risk for Pulmonary Hypertension

Hypothyroidism in Patients with Down Syndrome: Prevalence and Association with Congenital Heart Defects

Care of the adult patient with Down syndrome

Sex differences in cardiovascular disease and dysregulation in Down syndrome

Abstract 12562: DYRK1A/PPARG/EGR1 Pathway Elicits Endothelial Dysfunctions and Predispose to Developing Pulmonary Hypertension in Down Syndrome

Phenotyping Down syndrome: discovery and predictive modelling with electronic medical records

Susceptibility to COVID-19 Diagnosis in People with Down Syndrome Compared to the General Population: Matched-Cohort Study Using Primary Care Electronic Records in the UK

Publishing Trends in World Journal of Pediatric Surgery

Pulmonary Hypertension in Congenital Heart Disease: A Scientific Statement From the American Heart Association

Pulmonary hypertension associated with lung diseases

Infant pulmonary function tests in individuals with Down syndrome

Isogenic Pairs of Induced-Pluripotent Stem-Derived Endothelial Cells Identify DYRK1A/PPARG/EGR1 Pathway is Responsible for Down Syndrome-Associated Pulmonary Hypertension.

COVID‐19 in patients with Down syndrome: A systematic review